Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Francois Mullier is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Supervisor), Dogne, J.-M. (Co-supervisor), FAVRESSE, J. (CoI), Tre-Hardy, M. (CoI), Mullier, F. (CoI), Haguet, H. (Researcher), Hardy, M. (Researcher), Melchionda, S. (Researcher), BOUVY, C. (Researcher), Morimont, L. (Researcher), Gillot, C. (Researcher), Djokoto, H. (Researcher), Alpan, L. (Technician), Devel, P. (Technician), Modaffari, E. (Technician) & Maloteau, V. (Technician)
13/03/20 → …
Project: Research
-
The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J. (Supervisor), Mullier, F. (Co-supervisor), Haguet, H. (Researcher) & RONVAUX, L. (Researcher)
1/09/15 → …
Project: Research
-
The BIOCOAG project : Biological assessment of the control of anticoagulation
Douxfils, J. (PI), Mullier, F. (CoI), Dogne, J.-M. (CoI), Siriez, R. (Researcher), Evrard, J. (Researcher) & Vassart, J. (Researcher)
1/09/11 → …
Project: Research
-
The MAS project : Measure And See the activity of direct oral anticoagulant in the clinical context
Douxfils, J. (Researcher) & Mullier, F. (CoI)
Project: Research
-
Assessment of frailty in older patients before cardiac surgery
de SAINT HUBERT, M. (PI), Gourdin, M. (PI), Michaux, I. (PI), TOUSSAINT, O. (PI), Caron, N. (PI) & Mullier, F. (PI)
1/04/12 → 31/12/13
Project: Research
-
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogne, J.-M. & Douxfils, J., 7 Mar 2024, In: Thrombosis Research. 236, April 2024, p. 236-239 4 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile64 Downloads (Pure) -
Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963, (S0049384824000732), (10.1016/j.thromres.2024.03.001)]
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogné, J.-M. & Douxfils, J., Aug 2024, In: Thrombosis Research. 240, p. 109066 109066.Research output: Contribution to journal › Comment/debate › peer-review
-
Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma
Hardy, M., Douxfils, J., Xhaet, O., Robaye, B., Lessire, S., Lecompte, T. & Mullier, F., Dec 2024, In: Thrombosis Research. 244, p. 109194Research output: Contribution to journal › Article › peer-review
-
Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11, 860
Bareille, M., Lecompte, T., Mullier, F. & Roullet, S., Jan 2023, In: Journal of clinical medicine. 12, 2, 477.Research output: Contribution to journal › Letter › peer-review
Open AccessFile8 Downloads (Pure) -
Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectively
Bareille, M., Lecompte, T. & Mullier, F., Oct 2023, In: Thrombosis Research. 230, p. 33-36 4 p.Research output: Contribution to journal › Letter › peer-review
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 6 Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
Thesis
-
Quantification and characterization of microvesicles: applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer
Mullier, F. (Author)Dogne, J.-M. (Supervisor), Masereel, B. (President), Chatelain, B. (Co-Supervisor), Michiels, C. (Jury), Latinne, D. (Jury), Chatelain, C. (Jury), Wallemacq, P. (Jury), Harrison, P. A. (Jury) & Hoylaerts, M. F. (Jury), 26 Mar 2012Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Press/Media
-
Catholic University of Louvain (UCLouvain) Researchers Have Published New Data on Lupus (Is lupus anticoagulant testing with dilute Russell's viper venom clotting times reliable in the presence of inflammation?)
25/09/24
1 item of Media coverage
Press/Media: Expert Comment
-
Study Results from University of Namur Broaden Understanding of Coxsackievirus (Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome)
Dogne, J.-M., Douxfils, J., MULLIER, F. & Gillot, C.
10/01/23
1 item of Media coverage
Press/Media: Expert Comment
-
New Thrombosis Study Findings Recently Were Published by Researchers at Catholic University of Louvain (UCLouvain) (Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system)
28/12/22
1 item of Media coverage
Press/Media: Expert Comment
-
Department of Laboratory Medicine Researchers Provide New Data on Pulmonary Embolism (D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review)
9/12/22
1 item of Media coverage
Press/Media: Expert Comment
-
Reports from Namur Research Institute for Life Sciences (NARILIS) Add New Data to Research in Thrombosis and Haemostasis (Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy ...)
Siriez, R., Dogne, J.-M., Douxfils, J. & MULLIER, F.
24/11/22
1 item of Media coverage
Press/Media: Expert Comment